Biosimilars

Latest News

Getting ophthalmic biosimilars to market continues to prove difficult
Getting ophthalmic biosimilars to market continues to prove difficult

March 27th 2023

Representatives from Magellan Rx Management provided a detailed overview of current treatment options in ophthalmology and the impact that biosimilars could have.

International Harrington Prize jointly awarded to ophthalmologists
International Harrington Prize jointly awarded to ophthalmologists

March 8th 2023

Cardinal Health report examines shifts in biosimilars industry
Cardinal Health report examines shifts in biosimilars industry

February 27th 2023

Altos Biologics completes patient enrollment in global Phase 3 clinical trial of Eylea biosimilar in neovascular age-related macular degeneration
Altos Biologics completes patient enrollment in global Phase 3 clinical trial of Eylea biosimilar in neovascular age-related macular degeneration

February 26th 2023

Health policy implications for biosimilars: getting to the heart of the matter
How similar is a biosimilar?

February 22nd 2023

More News

© 2023 MJH Life Sciences

All rights reserved.